FDA announces commitment to modernize and streamline our food and nutrition programs to make sure that our investments of new and existing resources achieve their intended public health goals.
Category Archives: Drug Recalls & Safety Notices
FDA warns of fraudulent and unapproved flu products
FDA warns of fraudulent and unapproved flu products
FDA alerts health care professionals and patients not to use compounded drugs from Cantrell Drug Company; agency seeks action to stop production and distribution
FDA is alerting not to use drug products produced by Cantrell Drug Company that were distributed nationwide.
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance implementation of the new consumer Nutrition Facts label for foods
Americans rely on the U.S. Food and Drug Administration to ensure that food labels contain updated nutritional information to help them make more informed food choices that lead to better health for themselves and their families. I’ve made nutrition one of my top priorities, and ensuring that consumers have accurate and science-based information concerning the link between diet and chronic diseases like diabetes, obesity and heart disease is part of that commitment. We need to advance new ways to use the science we’re learning about diet and nutrition as tools for reducing the burden of disease. Our update to the iconic Nutrition Facts label includes significant changes to help consumers make more informed dietary choices, and we are already seeing the new label on many products.
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s ongoing efforts to help improve effectiveness of influenza vaccines
FDA provides update on flu vaccines during this severe flu season
Statement from Stephen Ostroff M.D., Deputy Commissioner for Foods and Veterinary Medicine, on National Toxicology Program draft report on Bisphenol A
FDA provides update on Clarity-BPA
FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid
FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid
FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing
Statement from FDA Commissioner Scott Gottlieb, M.D. on the efficacy of the 2017-2018 influenza vaccine
FDA provides update on flu vaccines during this severe flu season
FDA expands treatment window for use of clot retrieval devices in certain stroke patients
FDA expands treatment window for use of clot retrieval devices in certain stroke patient